J. L. Beard and J. R. Connor, Iron status and neural functioning. Annual review of nutrition, vol.23, pp.41-58, 2003.

A. A. Belaidi and A. I. Bush, Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics, J Neurochem, vol.139, issue.1, pp.179-197, 2016.

S. A. Benkovic and J. R. Connor, Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain, J Comp Neurol, vol.338, pp.97-113, 1993.

B. Bilgic, A. Pfefferbaum, T. Rohlfing, E. V. Sullivan, and E. Adalsteinsson, MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping, Neuroimage, vol.59, pp.2625-2660, 2012.

N. Boddaert, K. H. Le-quan-sang, A. Rotig, A. Leroy-willig, S. Gallet et al., Selective iron chelation in Friedreich ataxia: biologic and clinical implications, Blood, vol.110, pp.401-409, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00687082

S. Bodovitz, M. T. Falduto, D. E. Frail, and W. L. Klein, Iron levels modulate alphasecretase cleavage of amyloid precursor protein, J Neurochem, vol.64, pp.307-322, 1995.

M. C. Boll, J. Sotelo, E. Otero, M. Alcaraz-zubeldia, and C. Rios, Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease, Neurosci Lett, vol.265, pp.155-163, 1999.

C. Bonfio, L. Valer, S. Scintilla, S. Shah, D. J. Evans et al., UV-light-driven prebiotic synthesis of iron-sulfur clusters, Nature Chemistry, 2017.

A. Burkhart, T. Skjorringe, K. B. Johnsen, P. Siupka, L. B. Thomsen et al., Expression of Iron-Related Proteins at the Neurovascular Unit Supports Reduction and Reoxidation of Iron for Transport Through the Blood-Brain Barrier, Mol Neurobiol, vol.53, pp.7237-7253, 2016.

A. I. Bush and C. C. Curtain, Twenty years of metallo-neurobiology: where to now?, European Biophysics Journal, vol.37, pp.241-245, 2008.

Z. I. Cabantchik, A. Munnich, M. B. Youdim, and D. Devos, Regional siderosis: a new challenge for iron chelation therapy, Front Pharmacol, vol.4, p.167, 2013.

J. H. Caldwell, M. Klevanski, M. Saar, and U. C. Muller, Roles of the amyloid precursor protein family in the peripheral nervous system, Mech Dev, vol.130, pp.433-479, 2013.

J. Y. Cao and S. J. Dixon, Mechanisms of ferroptosis, Cell Mol Life Sci, vol.73, pp.2195-209, 2016.

K. L. Carpenter, W. Li, H. Wei, B. Wu, X. Xiao et al., Magnetic susceptibility of brain iron is associated with childhood spatial IQ, NeuroImage, vol.132, pp.167-174, 2016.

M. Castellanos, N. Puig, T. Carbonell, J. Castillo, J. Martinez et al., Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats, Brain Res, vol.952, pp.1-6, 2002.

A. Chan and T. B. Shea, Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency, J Alzheimers Dis, vol.9, pp.399-405, 2006.

P. Cheepsunthorn, C. Palmer, and J. R. Connor, Cellular distribution of ferritin subunits in postnatal rat brain, J Comp Neurol, vol.400, pp.73-86, 1998.

L. Chen, W. S. Hambright, R. Na, and Q. Ran, Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis, J Biol Chem, vol.290, pp.28097-106, 2015.

L. Chen, X. Li, L. Liu, B. Yu, Y. Xue et al., Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-gamma-lyase function, Oncol Rep, vol.33, pp.1465-74, 2015.

I. Y. Choi, P. Lee, J. Statland, A. Mcvey, M. Dimachkie et al., Reduction in cerebral antioxidant, glutathione (GSH), 2015.

L. D. Coles, P. J. Tuite, G. Oz, U. R. Mishra, R. V. Kartha et al., Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress, J Clin Pharmacol, vol.58, pp.158-167, 2018.

J. R. Connor, G. Pavlick, D. Karli, S. L. Menzies, and C. Palmer, A histochemical study of iron-positive cells in the developing rat brain, J Comp Neurol, vol.355, pp.111-134, 1995.

J. R. Connor, B. S. Snyder, P. Arosio, D. A. Loeffler, and P. Lewitt, A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains, J Neurochem, vol.65, pp.717-741, 1995.

J. R. Connor, B. S. Snyder, J. L. Beard, R. E. Fine, and E. J. Mufson, Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease, J Neurosci Res, vol.31, pp.327-362, 1992.

G. Cossu, G. Abbruzzese, G. Matta, D. Murgia, M. Melis et al., Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up, Parkinsonism Relat Disord, vol.20, pp.651-655, 2014.

. Crapper, D. R. Mclachlan, A. J. Dalton, T. P. Kruck, M. Y. Bell et al., Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet, vol.337, pp.1304-1312, 1991.

A. Crowe and E. H. Morgan, Iron and transferrrin uptake by brain and cerebrospinal fluid in the rat, Brain research, vol.592, pp.8-16, 1992.

P. Cutler, Iron overload and psychiatric illness, Can J Psychiatry, vol.39, pp.8-11, 1994.

L. M. De-lau and M. M. Breteler, Epidemiology of Parkinson's disease, The Lancet Neurology, vol.5, pp.525-535, 2006.

M. Decressac, B. Mattsson, M. Lundblad, P. Weikop, and A. Bjorklund, Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons, Neurobiol Dis, vol.45, pp.939-53, 2012.

L. Descamps, M. P. Dehouck, G. Torpier, and R. Cecchelli, Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells, Am J Physiol, vol.270, pp.1149-58, 1996.

D. Devos, C. Moreau, J. C. Devedjian, J. Kluza, M. Petrault et al., Targeting chelatable iron as a therapeutic modality in Parkinson's disease, Antioxid Redox Signal, vol.21, pp.195-210, 2014.

D. Dexter, F. Wells, A. Lee, F. Agid, Y. Agid et al., Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease, Journal of neurochemistry, vol.52, pp.1830-1836, 1989.

D. T. Dexter, A. Carayon, F. Javoy-agid, Y. Agid, F. R. Wells et al., Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia, Brain, vol.114, pp.1953-75, 1991.

D. T. Dexter, C. J. Carter, F. R. Wells, F. Javoy-agid, Y. Agid et al., Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease, J Neurochem, vol.52, pp.381-390, 1989.

D. T. Dexter, F. R. Wells, F. Agid, Y. Agid, A. J. Lees et al., Increased nigral iron content in postmortem parkinsonian brain, Lancet, vol.2, pp.1219-1239, 1987.

D. T. Dexter, F. R. Wells, A. J. Lees, F. Agid, Y. Agid et al., Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease, J Neurochem, vol.52, pp.1830-1836, 1989.

B. Ding, K. M. Chen, H. W. Ling, F. Sun, X. Li et al., Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease, J Magn Reson Imaging, vol.29, pp.793-801, 2009.

S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, vol.149, pp.1060-72, 2012.

S. J. Dixon, D. N. Patel, M. Welsch, R. Skouta, E. D. Lee et al., Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis, vol.3, p.2523, 2014.

. Do, B. Van, F. Gouel, A. Jonneaux, K. Timmerman et al., Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC, Neurobiol Dis, vol.94, pp.169-78, 2016.

S. Doll, B. Proneth, Y. Y. Tyurina, E. Panzilius, S. Kobayashi et al., ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition, Nat Chem Biol, vol.13, pp.91-98, 2017.

S. Dolma, S. L. Lessnick, W. C. Hahn, and B. R. Stockwell, Identification of genotypeselective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells, Cancer Cell, vol.3, pp.285-96, 2003.

G. A. Donnan, G. J. Hankey, and S. M. Davis, Intracerebral haemorrhage: a need for more data and new research directions, Lancet Neurol, vol.9, pp.133-137, 2010.

B. Drayer, P. Burger, R. Darwin, S. Riederer, R. Herfkens et al., MRI of brain iron, AJR Am J Roentgenol, vol.147, pp.103-113, 1986.

J. A. Duce, A. Tsatsanis, M. A. Cater, S. A. James, E. Robb et al., Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease, Cell, vol.142, pp.857-67, 2010.

O. M. El-agnaf and G. B. Irvine, Aggregation and neurotoxicity of alpha-synuclein and related peptides, Biochem Soc Trans, vol.30, pp.559-65, 2002.

W. S. Enochs, T. Sarna, L. Zecca, P. A. Riley, and H. M. Swartz, The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis, J Neural Transm Park Dis Dement Sect, vol.7, pp.83-100, 1994.

M. J. Farrer, Genetics of Parkinson disease: paradigm shifts and future prospects, Nat Rev Genet, vol.7, pp.306-324, 2006.

B. A. Faucheux, M. E. Martin, C. Beaumont, S. Hunot, J. J. Hauw et al., Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease, J Neurochem, vol.83, pp.320-350, 2002.

N. G. Faux, A. Rembach, J. Wiley, K. A. Ellis, D. Ames et al., An anemia of Alzheimer's disease, Mol Psychiatry, vol.19, pp.1227-1261, 2014.

N. G. Faux, C. W. Ritchie, A. Gunn, A. Rembach, A. Tsatsanis et al., PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses, J Alzheimers Dis, vol.20, pp.509-525, 2010.

J. M. Fearnley and A. J. Lees, Ageing and Parkinson's disease: substantia nigra regional selectivity, Brain, vol.114, pp.2283-301, 1991.

D. Feifel and C. W. Young, Iron overload among a psychiatric outpatient population, J Clin Psychiatry, vol.58, pp.74-82, 1997.

. Friedmann, J. P. Angeli, M. Schneider, B. Proneth, Y. Y. Tyurina et al., Nat Cell Biol, vol.16, pp.1180-91, 2014.

A. Gajowiak, A. Stys, R. R. Starzynski, R. Staron, and P. Lipinski, Misregulation of iron homeostasis in amyotrophic lateral sclerosis, Postepy Hig Med Dosw (Online), vol.70, pp.709-730, 2016.

L. Galluzzi, . Bravo-san, J. M. Pedro, and G. Kroemer, Ferroptosis in p53-dependent oncosuppression and organismal homeostasis, Cell Death Differ, vol.22, pp.1237-1245, 2015.

L. Galluzzi, I. Vitale, S. A. Aaronson, J. M. Abrams, D. Adam et al., Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death, Cell Death & Differentiation, vol.1, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01727577

M. Gao and X. Jiang, To eat or not to eat-the metabolic flavor of ferroptosis. Current opinion in cell biology, vol.51, pp.58-64, 2018.

M. Gao, P. Monian, Q. Pan, W. Zhang, J. Xiang et al., Ferroptosis is an autophagic cell death process, Cell Res, vol.26, pp.1021-1053, 2016.

M. Gao, P. Monian, N. Quadri, R. Ramasamy, and X. Jiang, Glutaminolysis and Transferrin Regulate Ferroptosis, Mol Cell, vol.59, pp.298-308, 2015.
DOI : 10.1016/j.molcel.2015.06.011
URL : https://doi.org/10.1016/j.molcel.2015.06.011

M. M. Gaschler, A. A. Andia, H. Liu, J. M. Csuka, B. Hurlocker et al., FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation, Nature Chemical Biology, vol.14, pp.507-515, 2018.
DOI : 10.1038/s41589-018-0031-6
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899674

J. W. Gawryluk, J. F. Wang, A. C. Andreazza, L. Shao, and L. T. Young, Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders, Int J Neuropsychopharmacol, vol.14, pp.123-153, 2011.

C. Ghadery, L. Pirpamer, E. Hofer, C. Langkammer, K. Petrovic et al., R2* mapping for brain iron: associations with cognition in normal aging, vol.36, pp.925-957, 2015.

K. Gnanapradeepan, S. Basu, T. Barnoud, A. Budina-kolomets, C. Kung et al., The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis, Frontiers in Endocrinology, p.9, 2018.

L. Goodman, Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis, J Nerv Ment Dis, vol.118, pp.97-130, 1953.

P. D. Griffiths and A. R. Crossman, Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease, Dementia, vol.4, pp.61-66, 1993.

G. Grolez, C. Moreau, B. Sablonniere, G. Garcon, J. C. Devedjian et al., Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease, BMC Neurol, p.74, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01264480

C. Guerreiro, B. Silva, A. C. Crespo, L. Marques, S. Costa et al., Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients, Biochim Biophys Acta, vol.1852, pp.2116-2138, 2015.

S. J. Guiney, P. A. Adlard, A. I. Bush, D. I. Finkelstein, and S. Ayton, Ferroptosis and cell death mechanisms in Parkinson's disease, Neurochem Int, vol.104, pp.34-48, 2017.
DOI : 10.1016/j.neuint.2017.01.004
URL : http://minerva-access.unimelb.edu.au/bitstream/11343/191300/1/Guiney%20et%20al%202017.pdf

J. N. Guzman, J. Sanchez-padilla, D. Wokosin, J. Kondapalli, E. Ilijic et al., Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1, Nature, vol.468, pp.696-700, 2010.
DOI : 10.1038/nature09536
URL : http://europepmc.org/articles/pmc4465557?pdf=render

E. M. Haacke, N. Y. Cheng, M. J. House, Q. Liu, J. Neelavalli et al., Imaging iron stores in the brain using magnetic resonance imaging, Magn Reson Imaging, vol.23, pp.1-25, 2005.

W. S. Hambright, R. S. Fonseca, L. Chen, R. Na, and Q. Ran, Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration, Redox Biol, vol.12, pp.8-17, 2017.

T. M. Hansen, H. Nielsen, N. Bernth, and T. Moos, Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain, Brain Res Mol Brain Res, vol.65, pp.186-97, 1999.

D. J. Hare, J. D. Doecke, N. G. Faux, A. Rembach, I. Volitakis et al., Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation, ACS Chem Neurosci, vol.6, pp.398-402, 2015.
DOI : 10.1021/cn5003557

D. J. Hare, A. Grubman, T. M. Ryan, A. Lothian, J. R. Liddell et al., Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry, Metallomics, vol.5, pp.1656-62, 2013.
DOI : 10.1039/c3mt00227f
URL : http://minerva-access.unimelb.edu.au/bitstream/11343/58836/1/Profiling%20the%20iron_Metallomics.pdf

D. J. Hare, P. Lei, S. Ayton, B. R. Roberts, R. Grimm et al., An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta, Chemical Science, vol.5, pp.2160-2169, 2014.

S. J. Hayflick, Neurodegeneration with brain iron accumulation: from genes to pathogenesis. Seminars in pediatric neurology, pp.182-185, 2006.
DOI : 10.1016/j.spen.2006.08.007

M. Heidari, D. Johnstone, B. Bassett, R. Graham, A. Chua et al., Brain iron accumulation affects myelinrelated molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features, p.1599, 2016.
DOI : 10.1038/mp.2015.192
URL : https://www.nature.com/articles/mp2015192.pdf

E. C. Hirsch, J. P. Brandel, P. Galle, F. Javoy-agid, and Y. Agid, Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis, J Neurochem, vol.56, pp.446-51, 1991.

E. Huang, W. Y. Ong, and J. R. Connor, Distribution of divalent metal transporter-1 in the monkey basal ganglia, Neuroscience, vol.128, pp.487-96, 2004.

E. Huang, W. Y. Ong, M. L. Go, and J. R. Connor, Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury, Exp Brain Res, vol.170, pp.376-86, 2006.

X. Huang, C. S. Atwood, R. D. Moir, M. A. Hartshorn, R. E. Tanzi et al., Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides, J Biol Inorg Chem, vol.9, pp.954-60, 2004.

X. Huang, M. P. Cuajungco, C. S. Atwood, M. A. Hartshorn, J. D. Tyndall et al.,

&. Bush and A. I. , Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem, vol.274, pp.37111-37117, 1999.

Y. Huang, Z. Dai, C. Barbacioru, and W. Sadee, Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance, Cancer Res, vol.65, pp.7446-54, 2005.

Y. Huang and R. W. Mahley, Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases, Neurobiol Dis, 72 Pt A, pp.3-12, 2014.

Y. A. Huang, B. Zhou, M. Wernig, and T. C. Sudhof, ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion, vol.168, pp.427-441, 2017.

S. W. Hulet, S. O. Heyliger, S. Powers, and J. R. Connor, Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis, J Neurosci Res, vol.61, pp.52-60, 2000.

I. Ingold, C. Berndt, S. Schmitt, S. Doll, G. Poschmann et al., Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis, Cell, 2017.

S. Y. Jeong and S. David, Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice, J Neurosci, vol.26, pp.9810-9819, 2006.

L. Jiang, N. Kon, T. Li, S. J. Wang, T. Su et al., Ferroptosis as a p53-mediated activity during tumour suppression, Nature, vol.520, pp.57-62, 2015.

K. Jomova, D. Vondrakova, M. Lawson, and M. Valko, Metals, oxidative stress and neurodegenerative disorders, vol.345, pp.91-104, 2010.

V. E. Kagan, G. Mao, F. Qu, J. P. Angeli, S. Doll et al., Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis, Nature chemical biology, vol.13, p.81, 2017.

H. S. Kain, N. Arang, E. Glennon, A. N. Douglass, D. R. Dudgeon et al., Ferroptosis-like signaling facilitates a potent innate defense against Plasmodium infection, p.257287, 2018.

P. J. Khandelwal, A. M. Herman, and C. E. Moussa, Inflammation in the early stages of neurodegenerative pathology, J Neuroimmunol, vol.238, pp.1-11, 2011.

L. W. Klomp, Z. S. Farhangrazi, L. L. Dugan, and J. D. Gitlin, Ceruloplasmin gene expression in the murine central nervous system, J Clin Invest, vol.98, pp.207-222, 1996.

M. Y. Kwon, E. Park, S. J. Lee, and S. W. Chung, Heme oxygenase-1 accelerates erastininduced ferroptotic cell death, Oncotarget, vol.6, pp.24393-403, 2015.

P. Langhorne, J. Bernhardt, and G. Kwakkel, Stroke rehabilitation, Lancet, vol.377, pp.1693-702, 2011.

C. Langkammer, S. Ropele, L. Pirpamer, F. Fazekas, and R. Schmidt, MRI for iron mapping in Alzheimer's disease, Neurodegener Dis, vol.13, pp.189-91, 2014.

L. Lannfelt, K. Blennow, H. Zetterberg, S. Batsman, D. Ames et al., Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial, Lancet Neurol, vol.7, pp.779-86, 2008.

P. Lei, S. Ayton, A. T. Appukuttan, I. Volitakis, P. A. Adlard et al., Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse, Neurobiol Dis, vol.81, pp.168-75, 2015.

P. Lei, S. Ayton, D. I. Finkelstein, P. A. Adlard, C. L. Masters et al., Tau protein: relevance to Parkinson's disease. The international journal of biochemistry & cell biology, vol.42, pp.1775-1778, 2010.

P. Lei, S. Ayton, D. I. Finkelstein, L. Spoerri, G. D. Ciccotosto et al., Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export, Nat Med, vol.18, pp.291-296, 2012.

P. Lei, S. Ayton, S. Moon, Q. Zhang, I. Volitakis et al., Motor and cognitive deficits in aged tau knockout mice in two background strains, Mol Neurodegener, vol.9, p.29, 2014.

Q. Li, X. Han, X. Lan, Y. Gao, J. Wan et al., Inhibition of neuronal ferroptosis protects hemorrhagic brain, JCI Insight, vol.2, p.90777, 2017.

T. Li, N. Kon, L. Jiang, M. Tan, T. Ludwig et al., Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence, Cell, vol.149, pp.1269-83, 2012.

A. Linkermann, R. Skouta, N. Himmerkus, S. R. Mulay, C. Dewitz et al., Synchronized renal tubular cell death involves ferroptosis, Proc Natl Acad Sci U S A, vol.111, pp.16836-16877, 2014.

B. Liu, A. Moloney, S. Meehan, K. Morris, S. E. Thomas et al., Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation, J Biol Chem, vol.286, pp.4248-56, 2011.

M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell, and W. R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci, vol.158, pp.47-52, 1998.

M. A. Lovell, S. Xiong, C. Xie, P. Davies, and W. R. Markesbery, Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3, J Alzheimers Dis, vol.6, pp.673-81, 2004.

Z. Luo, X. Zhuang, D. Kumar, X. Wu, C. Yue et al., The correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer's disease, PLoS One, vol.8, p.76203, 2013.

S. Ma, E. S. Henson, Y. Chen, and S. B. Gibson, Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells, Cell Death Dis, vol.7, p.2307, 2016.

F. Magni, G. Panduri, and N. Paolocci, Hypothermia triggers iron-dependent lipoperoxidative damage in the isolated rat heart, Free Radic Biol Med, vol.16, pp.465-76, 1994.

P. K. Mandal, S. Saharan, M. Tripathi, and G. Murari, Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease, Biol Psychiatry, vol.78, pp.702-712, 2015.

P. W. Mantyh, J. R. Ghilardi, S. Rogers, E. Demaster, C. J. Allen et al., Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide, J Neurochem, vol.61, pp.1171-1175, 1993.

A. Martin-bastida, R. J. Ward, R. Newbould, P. Piccini, D. Sharp et al., Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease, 2017.

D. Martin-sanchez, O. Ruiz-andres, J. Poveda, S. Carrasco, P. Cannata-ortiz et al., Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI, J Am Soc Nephrol, vol.28, pp.218-229, 2017.

S. Masaldan, S. A. Clatworthy, C. Gamell, P. M. Meggyesy, A. T. Rigopoulos et al., Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis, Redox Biol, vol.14, pp.100-115, 2018.

S. Masaldan, S. A. Clatworthy, C. Gamell, Z. M. Smith, P. S. Francis et al., Copper accumulation in senescent cells: Interplay between copper transporters and impaired autophagy, Redox Biol, vol.16, pp.322-331, 2018.

M. Matsushita, S. Freigang, C. Schneider, M. Conrad, G. W. Bornkamm et al., T cell lipid peroxidation induces ferroptosis and prevents immunity to infection, J Exp Med, vol.212, pp.555-68, 2015.

R. C. Mccarthy, Y. H. Park, and D. J. Kosman, sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin, EMBO Rep, vol.15, pp.809-824, 2014.

E. G. Meyron-holtz, M. C. Ghosh, K. Iwai, T. Lavaute, X. Brazzolotto et al., Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis, EMBO J, vol.23, pp.386-95, 2004.

C. E. Milligan, T. J. Cunningham, and P. Levitt, Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain, J Comp Neurol, vol.314, pp.125-160, 1991.

M. E. Monaco, C. J. Creighton, P. Lee, X. Zou, M. K. Topham et al., Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity, Transl Oncol, vol.3, pp.91-99, 2010.

D. A. Monti, G. Zabrecky, D. Kremens, T. Liang, N. A. Wintering et al., N-acetyl cysteine may support dopamine neurons in Parkinson's disease: Preliminary clinical and cell line data, PloS one, p.157602, 2016.

D. J. Moore, A. B. West, V. L. Dawson, and T. M. Dawson, Molecular pathophysiology of Parkinson's disease, Annu Rev Neurosci, vol.28, pp.57-87, 2005.

T. Moos, Developmental profile of non-heme iron distribution in the rat brain during ontogenesis, Brain Res Dev Brain Res, vol.87, pp.203-216, 1995.

T. Moos and E. H. Morgan, The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain, J Neurochem, vol.88, pp.233-278, 2004.

T. Moos, T. Nielsen, T. Skjorringe, and E. H. Morgan, Iron trafficking inside the brain, J Neurochem, vol.103, pp.1730-1770, 2007.

T. Moos, T. Skjoerringe, S. Gosk, and E. H. Morgan, Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1, J Neurochem, vol.98, pp.1946-58, 2006.

T. Moos, D. Trinder, and E. Morgan, Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain, Cellular and molecular biology, vol.46, pp.549-561, 2000.

C. Moreau, V. Danel, J. C. Devedjian, G. Grolez, K. Timmerman et al., Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis? Antioxid Redox Signal, 2018.

C. Moreau, J. A. Duce, O. Rascol, J. C. Devedjian, D. Berg et al., Iron as a therapeutic target for Parkinson's disease, Mov Disord, vol.33, pp.568-574, 2018.

N. V. Morgan, S. K. Westaway, J. E. Morton, A. Gregory, P. Gissen et al., PLA2G6, encoding a phospholipase A 2, is mutated in neurodegenerative disorders with high brain iron, Nature genetics, vol.38, p.752, 2006.

G. P. Morris, I. A. Clark, B. Vissel, and R. A. Nixon, Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease, Acta neuropathologica communications, vol.2, p.983, 2013.

S. Olivieri, A. Conti, S. Iannaccone, C. V. Cannistraci, A. Campanella et al., Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention, J Neurosci, vol.31, pp.18568-77, 2011.

M. Pandolfo, J. Arpa, M. B. Delatycki, K. H. Le-quan-sang, C. Mariotti et al., Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial, Ann Neurol, vol.76, pp.509-530, 2014.

S. Park, S. Kim, K. Park, S. Kim, J. Kim et al., Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease, Neuroscience letters, vol.363, pp.243-246, 2004.

B. N. Patel and S. David, A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes, Journal of Biological Chemistry, vol.272, 1997.

B. N. Patel, R. J. Dunn, and S. David, Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain, Journal of Biological Chemistry, vol.275, pp.4305-4310, 2000.

G. Perry, A. Nunomura, K. Hirai, X. Zhu, M. Perez et al., Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?, Free Radic Biol Med, vol.33, pp.1475-1484, 2002.

T. L. Perry, V. W. Yong, R. M. Clavier, K. Jones, J. M. Wright et al., Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse, Neurosci Lett, vol.60, pp.109-123, 1985.

A. Pfefferbaum, E. Adalsteinsson, T. Rohlfing, and E. V. Sullivan, MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods, Neuroimage, vol.47, pp.493-500, 2009.

L. Pirpamer, E. Hofer, B. Gesierich, F. De-guio, P. Freudenberger et al., Determinants of iron accumulation in the normal aging brain, Neurobiology of aging, vol.43, pp.149-155, 2016.

M. H. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia et al., Mutation in the alphasynuclein gene identified in families with Parkinson's disease, vol.276, pp.2045-2052, 1997.

D. Pratico and S. Sung, Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease, J Alzheimers Dis, vol.6, pp.171-176, 2004.

N. Pyatigorskaya, M. Sharman, J. C. Corvol, R. Valabregue, L. Yahia-cherif et al., High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry, Mov Disord, vol.30, pp.1077-84, 2015.

Y. Qi, T. M. Jamindar, and G. Dawson, Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes, J Neurochem, vol.64, pp.2458-64, 1995.

E. C. Radlowski and R. W. Johnson, Perinatal iron deficiency and neurocognitive development, Frontiers in human neuroscience, vol.7, p.585, 2013.

S. M. Raefsky, R. Furman, G. Milne, E. Pollock, P. Axelsen et al., Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid beta-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease, Neurobiol Aging, vol.66, pp.165-176, 2018.

A. K. Raina, A. Hochman, X. Zhu, C. A. Rottkamp, A. Nunomura et al., Abortive apoptosis in Alzheimer's disease, Acta Neuropathol, vol.101, pp.305-315, 2001.

T. J. Raub and C. R. Newton, Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells, J Cell Physiol, vol.149, pp.141-51, 1991.

J. C. Reed and M. Pellecchia, Ironing out cell death mechanisms, Cell, vol.149, pp.963-968, 2012.

T. T. Reed, W. M. Pierce, W. R. Markesbery, and D. A. Butterfield, Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD, Brain Res, vol.1274, pp.66-76, 2009.

C. W. Ritchie, A. I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk et al., Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial, Arch Neurol, vol.60, pp.1685-91, 2003.

J. T. Rogers, L. M. Leiter, J. Mcphee, C. M. Cahill, S. S. Zhan et al., Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences, J Biol Chem, vol.274, pp.6421-6452, 1999.

J. T. Rogers, J. D. Randall, C. M. Cahill, P. S. Eder, X. Huang et al., An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript, J Biol Chem, vol.277, pp.45518-45546, 2002.

J. L. Roh, E. H. Kim, H. J. Jang, J. Y. Park, and D. Shin, Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer, Cancer Lett, vol.381, pp.96-103, 2016.

M. Rohani, S. Razmeh, G. A. Shahidi, E. Alizadeh, and M. Orooji, A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients, Neurol Int, vol.9, p.7279, 2017.

N. Russo, M. Edwards, T. Andrews, M. O'brien, and K. P. Bhatia, Hereditary haemochromatosis is unlikely to cause movement disorders, Journal of neurology, vol.251, pp.849-852, 2004.
DOI : 10.1007/s00415-004-0445-9

J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-fischer et al., Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease, Proc Natl Acad Sci U S A, vol.105, pp.18578-83, 2008.

B. Sanyal, P. E. Polak, and S. Szuchet, Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes, J Neurosci Res, vol.46, pp.187-97, 1996.

H. M. Schipper, D. A. Bennett, A. Liberman, J. L. Bienias, J. A. Schneider et al., Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment, Neurobiol Aging, vol.27, pp.252-61, 2006.

D. L. Schonberg and D. M. Mctigue, Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation, Exp Neurol, vol.218, pp.64-74, 2009.
DOI : 10.1016/j.expneurol.2009.04.005
URL : http://europepmc.org/articles/pmc2703190?pdf=render

D. L. Schonberg, P. G. Popovich, and D. M. Mctigue, Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation, J Neuropathol Exp Neurol, vol.66, pp.1124-1159, 2007.

D. Schubert and M. Chevion, The role of iron in beta amyloid toxicity, Biochem Biophys Res Commun, vol.216, pp.702-709, 1995.

A. Sengupta, U. F. Lichti, B. A. Carlson, C. Cataisson, A. O. Ryscavage et al., Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2, J Invest Dermatol, vol.133, pp.1731-1772, 2013.

D. Serata, A. Del-casale, C. Rapinesi, I. Mancinelli, P. Pompili et al., Hemochromatosisinduced bipolar disorder: a case report, Gen Hosp Psychiatry, vol.34, pp.1-3, 2012.

A. L. Sessions, D. M. Doughty, P. V. Welander, R. E. Summons, and D. K. Newman, The continuing puzzle of the great oxidation event, Current Biology, vol.19, pp.567-574, 2009.

R. Shah, M. S. Shchepinov, and D. A. Pratt, Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis, 2018.

K. Shimada, R. Skouta, A. Kaplan, W. S. Yang, M. Hayano et al., Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis, Nature Chemical Biology, vol.12, p.497, 2016.

J. Sian, D. T. Dexter, A. J. Lees, S. Daniel, Y. Agid et al., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia, Ann Neurol, vol.36, pp.348-55, 1994.

L. Silvestri and C. Camaschella, A potential pathogenetic role of iron in Alzheimer's disease, J Cell Mol Med, vol.12, pp.1548-50, 2008.

E. P. Simpson, Y. K. Henry, J. S. Henkel, R. G. Smith, and S. H. Appel, Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden, Neurology, vol.62, pp.1758-65, 2004.

N. Singh, S. Haldar, A. K. Tripathi, K. Horback, J. Wong et al., Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities, Antioxid Redox Signal, vol.20, pp.1324-63, 2014.
DOI : 10.1089/ars.2012.4931
URL : http://europepmc.org/articles/pmc3935772?pdf=render

C. D. Smith, H. Chebrolu, D. R. Wekstein, F. A. Schmitt, G. A. Jicha et al., Brain structural alterations before mild cognitive impairment, Neurology, vol.68, pp.1268-73, 2007.
DOI : 10.1212/01.wnl.0000259542.54830.34

M. A. Smith, P. L. Harris, L. M. Sayre, and G. Perry, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc Natl Acad Sci U S A, vol.94, pp.9866-9874, 1997.

M. E. Strahan, A. Crowe, and E. H. Morgan, Iron uptake in relation to transferrin degradation in brain and other tissues of rats, Am J Physiol, vol.263, pp.924-933, 1992.

Y. K. Sung, S. Y. Hwang, M. K. Park, H. I. Bae, W. H. Kim et al., Fatty acidCoA ligase 4 is overexpressed in human hepatocellular carcinoma, Cancer Sci, vol.94, pp.421-425, 2003.
DOI : 10.1111/j.1349-7006.2003.tb01458.x

Y. Tao, Y. Wang, J. T. Rogers, and F. Wang, Perturbed iron distribution in Alzheimer's disease serum, cerebrospinal fluid, and selected brain regions: a systematic review and meta-analysis, J Alzheimers Dis, vol.42, pp.679-90, 2014.

A. Tarangelo, L. Magtanong, K. T. Bieging-rolett, Y. Li, J. Ye et al., p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells, Cell reports, vol.22, pp.569-575, 2018.

E. M. Taylor, A. Crowe, and E. H. Morgan, Transferrin and iron uptake by the brain: effects of altered iron status, Journal of neurochemistry, vol.57, pp.1584-1592, 1991.

B. Todorich, J. M. Pasquini, C. I. Garcia, P. M. Paez, and J. R. Connor, Oligodendrocytes and myelination: the role of iron, Glia, vol.57, pp.467-478, 2009.

B. Todorich, X. Zhang, and J. R. Connor, H-ferritin is the major source of iron for oligodendrocytes, Glia, vol.59, pp.927-962, 2011.

Q. Z. Tuo, P. Lei, K. A. Jackman, X. L. Li, H. Xiong et al., Tau-mediated iron export prevents ferroptotic damage after ischemic stroke, Mol Psychiatry, vol.22, pp.1520-1530, 2017.

T. Ueta, T. Inoue, T. Furukawa, Y. Tamaki, Y. Nakagawa et al., Glutathione peroxidase 4 is required for maturation of photoreceptor cells, J Biol Chem, vol.287, pp.7675-82, 2012.

S. J. Varma, K. B. Muchowska, P. Chatelain, and J. Moran, Native iron reduces CO2 to intermediates and end-products of the acetyl-CoA pathway, Nature Ecology & Evolution, 2018.

D. Velasco-sanchez, A. Aracil, R. Montero, A. Mas, L. Jimenez et al., Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia, Cerebellum, vol.10, pp.1-8, 2011.

C. Veyrat-durebex, P. Corcia, A. Mucha, S. Benzimra, C. Mallet et al., Iron metabolism disturbance in a French cohort of ALS patients, 2014.

V. S. Viswanathan, M. J. Ryan, H. D. Dhruv, S. Gill, O. M. Eichhoff et al., Nature, vol.547, pp.453-457, 2017.

L. Wan, G. Nie, J. Zhang, and B. Zhao, Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells, J Alzheimers Dis, vol.30, pp.523-553, 2012.

D. Wang, Y. Hui, Y. Peng, L. Tang, J. Jin et al., Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice, J Alzheimers Dis, vol.43, pp.519-553, 2015.

S. J. Wang, D. Li, Y. Ou, L. Jiang, Y. Chen et al., Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression, Cell Rep, vol.17, pp.366-373, 2016.

R. J. Ward, F. A. Zucca, J. H. Duyn, R. R. Crichton, and L. Zecca, The role of iron in brain ageing and neurodegenerative disorders, Lancet Neurol, vol.13, pp.1045-60, 2014.

B. X. Wong, S. Ayton, L. Q. Lam, P. Lei, P. A. Adlard et al., A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe(2+) under physiologically relevant conditions, Biochim Biophys Acta, vol.1840, pp.3299-310, 2014.

B. X. Wong, A. Tsatsanis, L. Q. Lim, P. A. Adlard, A. I. Bush et al., ?-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin, PLoS One, vol.9, p.114174, 2014.

M. Wortmann, M. Schneider, J. Pircher, J. Hellfritsch, M. Aichler et al., Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice, Circ Res, vol.113, pp.408-425, 2013.

X. Wu, F. Deng, Y. Li, G. Daniels, X. Du et al., ACSL4 promotes prostate cancer growth, invasion and hormonal resistance, Oncotarget, vol.6, pp.44849-63, 2015.

Y. Xie, W. Hou, X. Song, Y. Yu, J. Huang et al., Ferroptosis: process and function, Cell death and differentiation, vol.23, p.369, 2016.

H. Xu, V. M. Perreau, K. A. Dent, A. I. Bush, D. I. Finkelstein et al., Iron Regulates Apolipoprotein E Expression and Secretion in Neurons and Astrocytes, J Alzheimers Dis, vol.51, pp.471-87, 2016.
DOI : 10.3233/jad-150797

N. Yagoda, M. Von-rechenberg, E. Zaganjor, A. J. Bauer, W. S. Yang et al., RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels, Nature, vol.447, pp.864-872, 2007.
DOI : 10.1038/nature05859
URL : http://europepmc.org/articles/pmc3047570?pdf=render

A. Yamamoto, R. W. Shin, K. Hasegawa, H. Naiki, H. Sato et al., Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease, J Neurochem, vol.82, pp.1137-1184, 2002.

W. S. Yang, K. J. Kim, M. M. Gaschler, M. Patel, M. S. Shchepinov et al., Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis, Proc Natl Acad Sci U S A, vol.113, pp.4966-75, 2016.

W. S. Yang, R. Sriramaratnam, M. E. Welsch, K. Shimada, R. Skouta et al., Regulation of ferroptotic cancer cell death by GPX4, Cell, vol.156, pp.317-331, 2014.

W. S. Yang and B. R. Stockwell, Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells, Chem Biol, vol.15, pp.234-279, 2008.
DOI : 10.1016/j.chembiol.2008.02.010
URL : https://doi.org/10.1016/j.chembiol.2008.02.010

Y. Yu, Y. Xie, L. Cao, L. Yang, M. Yang et al., The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents, Mol Cell Oncol, vol.2, p.1054549, 2015.

L. Zecca, R. Pietra, C. Goj, C. Mecacci, D. Radice et al., Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain, J Neurochem, vol.62, pp.1097-101, 1994.

X. Zhang, N. Surguladze, B. Slagle-webb, A. Cozzi, and J. R. Connor, Cellular iron status influences the functional relationship between microglia and oligodendrocytes, Glia, vol.54, pp.795-804, 2006.
DOI : 10.1002/glia.20416

Y. H. Zhang, D. W. Wang, S. F. Xu, S. Zhang, Y. G. Fan et al., alpha-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice, Redox Biol, vol.14, pp.535-548, 2018.

M. Zille, S. S. Karuppagounder, Y. Chen, P. J. Gough, J. Bertin et al., Neuronal Death After Hemorrhagic Stroke In Vitro and In Vivo Shares Features of Ferroptosis and Necroptosis, Stroke, vol.48, pp.1033-1043, 2017.

G. Zorzi, F. Zibordi, L. Chiapparini, E. Bertini, L. Russo et al., Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial, Mov Disord, vol.26, pp.1756-1765, 2011.

F. A. Zucca, E. Basso, F. A. Cupaioli, E. Ferrari, D. Sulzer et al., Neuromelanin of the human substantia nigra: an update, Neurotox Res, vol.25, pp.13-23, 2014.

. Wenz, Enhanced ROS/lipid peroxidation, 2015.

S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, R. Skouta, E. M. Zaitsev et al., Ferroptosis: an iron-dependent form of nonapoptotic cell death, Cell, vol.149, pp.1060-72, 2012.

S. J. Dixon, D. N. Patel, M. Welsch, R. Skouta, E. D. Lee et al., Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis, vol.3, p.2523, 2014.

J. Table, L. Kon, N. Li, T. Wang, S. J. Su et al., Ferroptosis as a p53-mediated activity during tumour suppression, Nature, vol.520, pp.57-62, 2015.

E. Lachaier, C. Louandre, C. Godin, Z. Saidak, M. Baert et al., Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors, Anticancer Res, vol.34, pp.6417-6439, 2014.

A. Seiler, M. Schneider, H. Forster, S. Roth, E. K. Wirth et al., Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death, Cell Metab, vol.8, pp.237-285, 2008.

K. Shimada, R. Skouta, A. Kaplan, W. S. Yang, M. Hayano et al., Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis, BuOOH induces ferroptosis in human and murine cell lines, vol.12, pp.759-775, 2016.

J. H. Woo, Y. Shimoni, W. S. Yang, P. Subramaniam, A. Iyer et al., Elucidating Compound Mechanism of Action by Network Perturbation Analysis, Cell, vol.162, pp.441-451, 2015.

N. Yagoda, M. Von-rechenberg, E. Zaganjor, A. J. Bauer, W. S. Yang et al., RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels, Nature, vol.447, pp.864-872, 2007.

W. S. Yang, R. Sriramaratnam, M. E. Welsch, K. Shimada, R. Skouta et al., Regulation of ferroptotic cancer cell death by GPX4, Cell, vol.156, pp.317-331, 2014.